Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04769258
What this trial is testing

Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)

Who this might be right for
Inflammatory Bowel Diseases
Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) 1,380
Large-scale testing (Phase 3)UnknownNCT05599516
What this trial is testing

Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

Who this might be right for
COVID-19Coronavirus Infections
National Vaccine and Serum Institute, China 16,000
Not applicableStudy completedNCT04981392
What this trial is testing

Trusted Messengers: Intervention to Promote COVID-19 Vaccination

Who this might be right for
Covid19Vaccination
University of Massachusetts, Worcester 21,844
Not applicableStudy completedNCT05185687
What this trial is testing

Public Support for COVID-19 Test Allocation

Who this might be right for
Health EquityCOVID-19
University of Pennsylvania 2,019
Testing effectiveness (Phase 2)Study completedNCT04962893
What this trial is testing

Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine

Who this might be right for
Covid19
Ihsan GURSEL, PhD, Prof. 349
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06967428
What this trial is testing

Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort

Who this might be right for
Vaccine Adverse ReactionPost Acute Covid-19 Vaccination Syndrome
Independent Medical Alliance 100
Testing effectiveness (Phase 2)UnknownNCT04587219
What this trial is testing

The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older

Who this might be right for
Coronavirus Infection
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 110
Not applicableUnknownNCT05043246
What this trial is testing

Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease

Who this might be right for
Diseases, ChronicCovid19Adverse Reaction to Vaccine
The Second Affiliated Hospital of Chongqing Medical University 2,300
Testing effectiveness (Phase 2)Study completedNCT05104489
What this trial is testing

Dose-finding Study for AdimrSC-2f Vaccine

Who this might be right for
COVID-19
Adimmune Corporation 241
Testing effectiveness (Phase 2)Study completedNCT06283459
What this trial is testing

Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2

Who this might be right for
SARS CoV 2 Infection
Imunon 24
Early research (Phase 1)Study completedNCT05435027
What this trial is testing

Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)

Who this might be right for
COVID-19SARS-CoV-2
Gritstone bio, Inc. 342
Testing effectiveness (Phase 2)UnknownNCT04713488
What this trial is testing

An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

Who this might be right for
COVID-19 Prevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 110
Not applicableWithdrawnNCT04894682
What this trial is testing

Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor

Who this might be right for
Lung CancerPulmonary Nodule, SolitaryPulmonary Nodule, Multiple+3 more
Guangdong Provincial People's Hospital
Early research (Phase 1)UnknownNCT04838080
What this trial is testing

Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo

Who this might be right for
COVID-19 Vaccine
Kocak Farma 38
Not applicableStudy completedNCT04706403
What this trial is testing

Views on COVID-19 and Vaccination

Who this might be right for
Covid19
University of Massachusetts, Worcester 756
Large-scale testing (Phase 3)WithdrawnNCT05124561
What this trial is testing

Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)

Who this might be right for
COVID-19
CanSino Biologics Inc.
Large-scale testing (Phase 3)Ended earlyNCT05022329
What this trial is testing

COVID-19 Vaccine Boosters in Patients With CKD

Who this might be right for
Chronic Kidney DiseasesCOVID-19
Sunnybrook Health Sciences Centre 273
Testing effectiveness (Phase 2)UnknownNCT05069129
What this trial is testing

Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above

Who this might be right for
COVID-19 PneumoniaCoronavirus Infections
National Vaccine and Serum Institute, China 1,848
Not applicableStudy completedNCT05089045
What this trial is testing

Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 360
Early research (Phase 1)UnknownNCT05171946
What this trial is testing

Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults

Who this might be right for
SafetyVaccine ReactionVaccine Adverse Reaction+1 more
Iman Almansour 30
Next Page